Enzymatica
3,4 SEK +2,1 %Vær den første som følger denne virksomhed
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray which can prevent colds as well as shorten the illness period. The product has been launched on several markets and the strategy is to expand to more markets via partners. The company is headquartered in Lund.
Omsætning
48,95 mio.
EBIT %
-139,37 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ENZY
Daglig lav / høj pris
3,325 / 3,695
SEK
Markedsværdi
558,47 mio. SEK
Aktieomsætning
438,61 t SEK
Volumen
128 t
Finanskalender
Delårsrapport
07.11.2023
Årsrapport
16.02.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Mats Andersson, privat och genom bolag | 22,2 % | 22,2 % |
| Roosgruppen AB | 13,6 % | 13,6 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper